Handelsbanken Fonder AB - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$155
-54.7%
13,5000.0%0.00%
-50.0%
Q2 2023$342
-6.0%
13,500
+19.5%
0.00%0.0%
Q1 2023$364
+74.2%
11,3000.0%0.00%
+100.0%
Q4 2022$209
-99.9%
11,300
+18.9%
0.00%
-50.0%
Q3 2022$256,000
-2.7%
9,500
-41.0%
0.00%
+100.0%
Q4 2021$263,000
-41.4%
16,1000.0%0.00%
-50.0%
Q3 2021$449,000
-5.9%
16,1000.0%0.00%0.0%
Q2 2021$477,00016,1000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$156,130,00032.47%
Camber Capital Management LP 630,000$21,420,0001.40%
Granite Point Capital Management, L.P. 50,000$1,700,0001.17%
Rhenman & Partners Asset Management AB 82,000$2,788,0000.83%
Geduld E E 25,001$850,0000.53%
Pier Capital, LLC 106,985$3,637,0000.52%
Ghost Tree Capital, LLC 20,000$680,0000.48%
ArrowMark Colorado Holdings LLC 433,457$14,738,0000.42%
Polar Capital LLP 577,042$19,618,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,500$8,721,0000.35%
View complete list of REVANCE THERAPEUTICS INC shareholders